Action
For the non-surgical closure of a patent foramen ovale (PFO) in patients with recurrent cryptogenic stroke due to presumed paradoxical embolism through a patent foramen ovale. Chronic antiplatelet therapy (ASA or clopidogrel or association of ASA & dipyridamole).

Status

Trial(s)
  = Ongoing
  = Completed

	CLOSE	Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
	PC-Trial	Patent foramen ovale and Cryptogenic embolism

UID: 305